The GSEA results indicated that ARNTL2 is implicated in several signaling pathways, including T cell receptor signaling pathway, renal cell carcinoma, focal adhesion, JAK-STAT signaling pathway, and cell cycle pathway. This evidence concerns the gene BMAL2 and hereditary clear cell renal cell carcinoma.